| Autor: |
Koehn LM; Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI 02905, USA., Nguyen K; Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI 02905, USA., Chen X; Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI 02905, USA., Santoso A; ProThera Biologics, Inc., Providence, RI 02905, USA., Tucker R; Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI 02905, USA., Lim YP; ProThera Biologics, Inc., Providence, RI 02905, USA., Stonestreet BS; Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI 02905, USA. |
| Abstrakt: |
Hypoxia-ischemia (HI)-related brain injury is an important cause of morbidity and long-standing disability in newborns. We have previously shown that human plasma-derived inter-alpha inhibitor proteins (hIAIPs) attenuate HI-related brain injury in neonatal rats. The optimal dose of hIAIPs for their neuroprotective effects and improvement in behavioral outcomes remains to be determined. We examined the efficacy of 30, 60, or 90 mg/kg of hIAIPs administered to neonatal rats after exposure to HI for 2 h. Postnatal day 7 (P7) Wistar rats were exposed to either sham-surgery or unilateral HI (right carotid artery ligation, 2 h of 8% O 2 ) brain injury. A placebo, 30, 60, or 90 mg/kg of hIAIPs were injected intraperitoneally at 0, 24 and 48 h after HI ( n = 9-10/sex). We carried out the following behavioral analyses: P8 (righting reflex), P9 (negative geotaxis) and P10 (open-field task). Rats were humanely killed on P10 and their brains were stained with cresyl violet. Male extension/contraction responses and female righting reflex times were higher in the HI placebo groups than the sham groups. Female open-field exploration was lower in the HI placebo group than the sham group. hIAIPs attenuated these behavioral deficits. However, the magnitude of the responses did not vary by hIAIP dose. hIAIPs reduced male brain infarct volumes in a manner that correlated with improved behavioral outcomes. Increasing the hIAIP dose from 30 to 90 mg/kg did not further accentuate the hIAIP-related decreases in infarct volumes. We conclude that larger doses of hIAIPs did not provide additional benefits over the 30 mg/kg dose for behavior tasks or reductions in infarct volumes in neonatal rats after exposure to severe HI. |
